# Max Hodak

From Restoring Sight to 'Consciousness Machines': Neuralink Co‑founder Says BCI Is Entering a Takeoff Era — and Predicts Humans May Live to 1,000

A retinal implant developed by Max Hodak’s company Science has reportedly restored coherent visual percepts in more than 40 blind patients and published results in the New England Journal of Medicine. Hodak frames this clinical success as the start of a BCI "takeoff era," outlining ambitious plans for biohybrid implants, deep AI–neuroscience convergence, and even radical longevity claims that the first 1,000‑year humans may already be alive.